Development of an Orally Bioavailable Isoliquiritigenin Self-Nanoemulsifying Drug Delivery System to Effectively Treat Ovalbumin-Induced Asthma

PURPOSE: Isoliquiritigenin (ILQ), an important component of Anti-Asthma Herbal Medicine Intervention (ASHMI), had shown potent anti-asthma effect in vitro in our previous study. However, poor solubility and low bioavailability hindered in vivo application to treat asthma. This study was to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Mingzhuo, Zhan, Mengling, Wang, Zheng, Wang, Zeqian, Li, Xiu-Min, Miao, Mingsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671486/
https://www.ncbi.nlm.nih.gov/pubmed/33223829
http://dx.doi.org/10.2147/IJN.S269982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671486/
https://www.ncbi.nlm.nih.gov/pubmed/33223829
http://dx.doi.org/10.2147/IJN.S269982

Ejemplares similares